<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00795951</url>
  </required_header>
  <id_info>
    <org_study_id>MEKOS 07 29P1/2/3/401</org_study_id>
    <nct_id>NCT00795951</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents</brief_title>
  <official_title>Clinical Evaluation of T.R.U.E. TESTÂ® Panel 1.1, 2.1 and 3.1: in Children and Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allerderm</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allerderm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E.
      TEST allergens in children and adolescents ages 6-18.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three T.R.U.E. TEST panels (1.1, 2.1 and 3.1) containing 28 allergens and a negative control
      will be applied to the skin on the subject's back and worn for approximately 48 hours. Patch
      test site skin reactions will be evaluated at days 2, 3 (+1), 7 and 21 following panel
      application
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive Reactions: Nickel Sulfate</measure>
    <time_frame>Visit 3: 3-4 after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Neomycin Sulfate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Wool Alcohol</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Potassium Dichromate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Caine Mix</measure>
    <time_frame>Visit 3: 72-96 hours after patch application, Visit 4: 1 week after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Fragrance Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Colophony</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Paraben Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Negative Control</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Balsam of Peru</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Ethylenediamine Dihydrochloride</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days week after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Cobalt Dichloride</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: P-tert Butylphenol Formadehyde Resin</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Epoxy Resin</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Carba Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Black Rubber Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Cl+Me-Isothiazolinone</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Quaternium-15</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Mercaptobenzothiazole</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: p-Phenylenediamine</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Formaldehyde</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Mercapto Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Thimerosal</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Thiuram Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Diazolidinyl Urea</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Imidazolidinyl Urea</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Budesonide</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Tixocortol-21-pivalate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Reactions: Quinoline Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Nickel Sulfate</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Neomycin Sulfate</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Wool Alcohol</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Potassium Dichromate</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Caine Mix</measure>
    <time_frame>Visit 4: 1 week after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Fragrance Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Colophony</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Paraben Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Negative Control</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Balsam of Peru</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Ethylenediamine Dihydrochloride</measure>
    <time_frame>Visit 4: 7 days week after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Cobalt Dichloride</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: P-tert Butylphenol Formadehyde Resin</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Epoxy Resin</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Carba Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Black Rubber Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Cl+Me-Isothiazolinone</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Quaternium-15</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Mercaptobenzothiazole</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: p-Phenylenediamine</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Formaldehyde</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Mercapto Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Thimerosal</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Thiuram Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Diazolidinyl Urea</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Imidazolidinyl Urea</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Budesonide</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Tixocortol-21-pivalate</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Reactions: Quinoline Mix</measure>
    <time_frame>Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Nickel Sulfate</measure>
    <time_frame>Visit 3: 3-4 after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Neomycin Sulfate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Wool Alcohol</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Potassium Dichromate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Caine Mix</measure>
    <time_frame>Visit 3: 72-96 hours after patch application, Visit 4: 1 week after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Fragrance Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Colophony</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Paraben Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Negative Control</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Balsam of Peru</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Ethylenediamine Dihydrochloride</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days week after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Cobalt Dichloride</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: P-tert Butylphenol Formadehyde Resin</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Epoxy Resin</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Carba Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Black Rubber Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Cl+Me-Isothiazolinone</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Quaternium-15</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: p-Phenylenediamine</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Formaldehyde</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Mercapto Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Thimerosal</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Thiuram Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Diazolidinyl Urea</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Imidazolidinyl Urea</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Budesonide</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Tixocortol-21-pivalate</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Quinoline Mix</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Reactions: Mercaptobenzothiazole</measure>
    <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
    <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Panel Adhesion Evaluation</measure>
    <time_frame>Visit 2 (day 1) prior to panel removal.</time_frame>
    <description>Panel Adhesion was evaluated according to the following score scale: Off: Test panel fell off, Poor: little to no skin to panel contact, Fair: skin to panel contact variable, tape edges lifting, Good: skin contact acceptable, some tape edges loose; Excellent, skin contact good, tape edges adherent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Panel Irritation</measure>
    <time_frame>Visit 2 (day 1) following to panel removal.</time_frame>
    <description>Panel Irritation was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Reported Itching and Burning</measure>
    <time_frame>Visit 2 (day 1) following to panel removal.</time_frame>
    <description>Subject reported itching/burning was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Dermatitis, Contact</condition>
  <arm_group>
    <arm_group_label>TRUE Test panels 1.1, 2.1, 3.1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects were patched with 3 T.R.U.E. Test panels containing 28 allergens and 1 negative control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>T.R.U.E. Test</intervention_name>
    <description>48 hour application of 28 allergens and negative control</description>
    <arm_group_label>TRUE Test panels 1.1, 2.1, 3.1</arm_group_label>
    <other_name>NA no other names</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptoms and history potentially consistent with allergic contact dermatitis based on
             symptoms and clinical history (i.e., subjects are visiting the clinic/physician to
             diagnose, treat or resolve this condition).

          -  Children and adolescents 6 to 18 years of age, and in general good health.

          -  Adolescent females 15 years of age or older (or with menarche) must consent to a urine
             pregnancy test; urine test results must be negative for study inclusion.

          -  Informed consent must be signed and understood by subject. If underage, informed
             consent must be signed and understood by parent or legal guardian, consistent with all
             institutional, local and national regulations.

        Exclusion Criteria:

          -  Topical corticosteroid treatment during the last 7 days on or near the test area.

          -  Systemic treatment with corticosteroids or other immunosuppressive during the last 7
             days.

          -  Subjects currently receiving (or received during the previous 3 weeks) other
             investigational drugs, treatments or devices, or participating in another clinical
             study.

          -  Treatment with ultraviolet (UV) light (including tanning) during the previous 3 weeks.

          -  Acute dermatitis outbreak or dermatitis on or near the test area on the back.

          -  Subjects unable to comply with activity restrictions (e.g., protecting test panels
             from excess moisture due to showering or vigorous activity).

          -  Subjects unable or unwilling to comply with multiple return visits.

          -  Female subjects 15 years of age (or with onset of menarche) and older unable to
             consent to a urine pregnancy test, or those with a positive pregnancy test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Eichenfield, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>November 20, 2008</study_first_submitted>
  <study_first_submitted_qc>November 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2008</study_first_posted>
  <results_first_submitted>February 19, 2013</results_first_submitted>
  <results_first_submitted_qc>December 19, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 11, 2014</results_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>allergic</keyword>
  <keyword>contact dermatitis</keyword>
  <keyword>contact allergy</keyword>
  <keyword>Type IV</keyword>
  <keyword>Children</keyword>
  <keyword>TRUE TEST</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Single Site- Rady Children's Hospital Recruiting Period-09 December 2008 (first subject enrolled) 27 October 2009 (last subject exited)</recruitment_details>
      <pre_assignment_details>No significant events or approaches</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>All Subjects</title>
          <description>T.R.U.E. Test Allergen Panel evaluations</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm Study</title>
          <description>All subjects were patched with TRUE Test panels 1.1, 2.1 and 3.1</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.6" spread="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Nickel Sulfate</title>
        <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Nickel Sulfate</title>
          <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Neomycin Sulfate</title>
        <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Neomycin Sulfate</title>
          <description>Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Wool Alcohol</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Wool Alcohol</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Potassium Dichromate</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Potassium Dichromate</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Caine Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 72-96 hours after patch application, Visit 4: 1 week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Diagnostic Performance</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Caine Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Fragrance Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Fragrance Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Colophony</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Colophony</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Paraben Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Paraben Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Negative Control</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Negative Control</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Balsam of Peru</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Balsam of Peru</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Ethylenediamine Dihydrochloride</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Ethylenediamine Dihydrochloride</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Cobalt Dichloride</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Cobalt Dichloride</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: P-tert Butylphenol Formadehyde Resin</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: P-tert Butylphenol Formadehyde Resin</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Epoxy Resin</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Epoxy Resin</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Carba Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Carba Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Black Rubber Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Black Rubber Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Cl+Me-Isothiazolinone</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Cl+Me-Isothiazolinone</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Quaternium-15</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Quaternium-15</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Mercaptobenzothiazole</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Mercaptobenzothiazole</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: p-Phenylenediamine</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: p-Phenylenediamine</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Formaldehyde</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Formaldehyde</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Mercapto Mix</title>
        <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Mercapto Mix</title>
          <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Thimerosal</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Thimerosal</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Thiuram Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Thiuram Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Diazolidinyl Urea</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Diazolidinyl Urea</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Imidazolidinyl Urea</title>
        <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Imidazolidinyl Urea</title>
          <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Budesonide</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Budesonide</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Tixocortol-21-pivalate</title>
        <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Tixocortol-21-pivalate</title>
          <description>Number of subjects with positive reactions at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Reactions: Quinoline Mix</title>
        <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Reactions: Quinoline Mix</title>
          <description>Number of subjects with positive reactions recorded at visit 3 and/or visit 4</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Nickel Sulfate</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Nickel Sulfate</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Neomycin Sulfate</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Neomycin Sulfate</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Wool Alcohol</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Wool Alcohol</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Potassium Dichromate</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Potassium Dichromate</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Caine Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 1 week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Diagnostic Performance</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Caine Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Fragrance Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Fragrance Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Colophony</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Colophony</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Paraben Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Paraben Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Negative Control</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Negative Control</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Balsam of Peru</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Balsam of Peru</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Ethylenediamine Dihydrochloride</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Ethylenediamine Dihydrochloride</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Cobalt Dichloride</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Cobalt Dichloride</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: P-tert Butylphenol Formadehyde Resin</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: P-tert Butylphenol Formadehyde Resin</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Epoxy Resin</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Epoxy Resin</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Carba Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Carba Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Black Rubber Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Black Rubber Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Cl+Me-Isothiazolinone</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Cl+Me-Isothiazolinone</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Quaternium-15</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Quaternium-15</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Mercaptobenzothiazole</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Mercaptobenzothiazole</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: p-Phenylenediamine</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: p-Phenylenediamine</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Formaldehyde</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Formaldehyde</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Mercapto Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Mercapto Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Thimerosal</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Thimerosal</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Thiuram Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Thiuram Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Diazolidinyl Urea</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Diazolidinyl Urea</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Imidazolidinyl Urea</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Imidazolidinyl Urea</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Budesonide</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Budesonide</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Tixocortol-21-pivalate</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Tixocortol-21-pivalate</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Reactions: Quinoline Mix</title>
        <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
        <time_frame>Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Late Reactions: Quinoline Mix</title>
          <description>Number of subjects with late reactions, defined as a positive reaction that initially occurs at day 7 (visit 4) or later.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Nickel Sulfate</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Nickel Sulfate</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Neomycin Sulfate</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Neomycin Sulfate</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Wool Alcohol</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Wool Alcohol</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Potassium Dichromate</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Potassium Dichromate</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Caine Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 72-96 hours after patch application, Visit 4: 1 week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Caine Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Fragrance Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Fragrance Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Colophony</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Colophony</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Paraben Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Paraben Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Negative Control</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Negative Control</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Balsam of Peru</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Balsam of Peru</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Ethylenediamine Dihydrochloride</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days week after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Ethylenediamine Dihydrochloride</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Cobalt Dichloride</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Cobalt Dichloride</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: P-tert Butylphenol Formadehyde Resin</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: P-tert Butylphenol Formadehyde Resin</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Epoxy Resin</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Epoxy Resin</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Carba Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Carba Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Black Rubber Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Black Rubber Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Cl+Me-Isothiazolinone</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Cl+Me-Isothiazolinone</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Quaternium-15</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Quaternium-15</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: p-Phenylenediamine</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: p-Phenylenediamine</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Formaldehyde</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Formaldehyde</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Mercapto Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Mercapto Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Thimerosal</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Thimerosal</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Thiuram Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Thiuram Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Diazolidinyl Urea</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Diazolidinyl Urea</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Imidazolidinyl Urea</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Imidazolidinyl Urea</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Budesonide</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Budesonide</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Tixocortol-21-pivalate</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Tixocortol-21-pivalate</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Quinoline Mix</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Quinoline Mix</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Reactions: Mercaptobenzothiazole</title>
        <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
        <time_frame>Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application</time_frame>
        <population>Number of participants analyzed includes all subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Reactions: Mercaptobenzothiazole</title>
          <description>Number of subjects with persistent reactions defined as positive reactions identified at visit 3 or 4 that are still present at the next visit.</description>
          <population>Number of participants analyzed includes all subjects who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Panel Adhesion Evaluation</title>
        <description>Panel Adhesion was evaluated according to the following score scale: Off: Test panel fell off, Poor: little to no skin to panel contact, Fair: skin to panel contact variable, tape edges lifting, Good: skin contact acceptable, some tape edges loose; Excellent, skin contact good, tape edges adherent.</description>
        <time_frame>Visit 2 (day 1) prior to panel removal.</time_frame>
        <population>All subjects who completed the study are included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Panel Adhesion Evaluation</title>
          <description>Panel Adhesion was evaluated according to the following score scale: Off: Test panel fell off, Poor: little to no skin to panel contact, Fair: skin to panel contact variable, tape edges lifting, Good: skin contact acceptable, some tape edges loose; Excellent, skin contact good, tape edges adherent.</description>
          <population>All subjects who completed the study are included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Panel 1 Adhesion Scores</title>
              <category_list>
                <category>
                  <title>Excellent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fair</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fell off</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 2 Adhesion Scores</title>
              <category_list>
                <category>
                  <title>Excellent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fair</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fell off</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 3 Adhesion Scores</title>
              <category_list>
                <category>
                  <title>Excellent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fair</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fell off</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Panel Irritation</title>
        <description>Panel Irritation was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
        <time_frame>Visit 2 (day 1) following to panel removal.</time_frame>
        <population>All subjects who completed the study are included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Panel Irritation</title>
          <description>Panel Irritation was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
          <population>All subjects who completed the study are included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Panel 1 Irritation</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 2 Irritation</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 3 Irritation</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Reported Itching and Burning</title>
        <description>Subject reported itching/burning was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
        <time_frame>Visit 2 (day 1) following to panel removal.</time_frame>
        <population>All subjects who completed the study are included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>T.R.U.E. Test allergen panel evaluations</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported Itching and Burning</title>
          <description>Subject reported itching/burning was scored according to the following descriptors; None, Weak, Moderate, Strong (not defined in protocol)</description>
          <population>All subjects who completed the study are included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Panel 1 Itching and Burning</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 2 Itching and Burning</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Panel 3 Itching and Burning</title>
              <category_list>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Weak</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Strong</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The Adverse Event-Reporting Period for each study subject began at application of the patch test and ended with the Day 21 visit.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Safety</title>
          <description>Adverse Events</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Worsening of rash</sub_title>
                <counts group_id="E1" events="34" subjects_affected="26" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Flare-up of rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Boil on forehead</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Reaction around panel 2.1</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Edema, vesiculation pain on hands</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Worsening of underlying condition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Slight worsening of spot on leg</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Lesion on right thumb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Worsening of dermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Reaction on place of panel</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>SE Jacob, MD and L Eichenfield, MD</name_or_title>
      <organization>Rady Childrenâs Hospital, San Diego, CA</organization>
      <phone>858-576-1700 ext 4825</phone>
      <email>leichenfield@rchsd.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

